icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
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
gaLeqawRJQVs1V8K